| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| MYOD1 |
myocytes |
10 hours in differentiating medium |
Permissive
Robust
|
Mus musculus |
GSE24852
...
|
MA0499.2
|
| MYOD1 |
myotube |
48 hours in differentiating medium |
Permissive
Robust
|
Mus musculus |
GSE24852
...
|
MA0499.2
|
| MYOD1 |
P19 (embryonic carcinoma) |
MyoD transduction |
Permissive
Robust
|
Mus musculus |
GSE64626
...
|
MA0499.2
|
| MYOD1 |
P19 (embryonic carcinoma) |
MyoD transduction |
Permissive
Robust
|
Mus musculus |
GSE64626
...
|
MA0499.2
|
| MYOD1 |
C2C12 (myoblasts) |
day3 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE80812
...
|
MA0499.2
|
| MYOD1 |
C2C12 (myoblasts) |
day3 of differentiation, KLF5 KO |
Permissive
Robust
|
Mus musculus |
GSE80812
...
|
MA0499.2
|
| MYOD1 |
C2C12 (myoblasts) |
differentiated |
Permissive
Robust
|
Mus musculus |
GSE63716
...
|
MA0499.2
|
| MYOD1 |
C2C12 (myoblasts) |
Day: 2 of differentiation Celltype: myoblast |
Permissive
|
Mus musculus |
GSE69527
...
|
MA0499.2
|
| MYOD1 |
C2C12 (myoblasts) |
Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturer’s protocol |
Permissive
|
Mus musculus |
GSE69527
...
|
MA0499.2
|
| MYOD1 |
embryonic stem cells |
Treatment: doxycycline Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac |
Permissive
|
Mus musculus |
GSE97712
...
|
MA0499.2
|
Showing 10 records in page 572
from 963 pages